Literature DB >> 11792159

Single small enhancing computed tomographic (CT) lesions in Indian patients with new-onset seizures. A prospective follow-up in 75 patients.

M K Singh1, R K Garg, G Nath, D N Verma, S Misra.   

Abstract

This study was planned to observe the clinical and radiological course of single small enhancing CT lesions in Indian patients presenting with new-onset-seizures. In this study, 75 patients with new-onset seizures and a single enhancing CT lesion were prospectively followed up for 1 year. All patients fulfilled the criteria of cysticercus granuloma. The repeat CT scans were performed 2 months after the first CT scan. Antiepileptic drug therapy was the only form of treatment given. The majority of patients were below 20 years of age. Simple partial seizure, with or without secondary generalization, was the commonest type of seizure encountered in these patients. In follow-up CT scans 84% of patients showed either disappearance or regression in the size of lesion. The proportion of patients showing complete disappearance of CT lesions was 0.73 (95% CI, 0.61-0.80). In 11 (15%) patients the lesions were calcified. In nine patients, in whom the lesion had persisted or regressed, another follow-up CT scan (6 months after the second scan) revealed either complete disappearance or calcification of the lesions. The majority (86.6%) of patients remained seizure free for 1 year after starting antiepileptic drugs. Ten patients experienced seizure recurrences within the first month of therapy. The proportion of patients who remained seizure free was 0.86 (95% CI, 0.76-0.92). Four patients experienced seizure recurrence even after complete disappearance of CT lesions. In the majority of patients the lesions disappeared spontaneously and in a few the lesions calcified; hence these patients did not require anticysticercal therapy. Antiepileptic therapy was helpful in controlling further recurrences of seizures in most of the patients. A few patients experienced seizures even after disappearance of CT lesions. Copyright 2001 BEA Trading Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11792159     DOI: 10.1053/seiz.2001.0558

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  6 in total

Review 1.  Cysticerci-related single parenchymal brain enhancing lesions in non-endemic countries.

Authors:  Oscar H Del Brutto; Theodore E Nash; Hector H Garcia
Journal:  J Neurol Sci       Date:  2012-05-31       Impact factor: 3.181

2.  Natural course of typical and atypical parenchymal solitary cysticercus granuloma of the brain: a 3-year prospective clinico-radiological study.

Authors:  Neeraj Kumar; Ravindra Kumar Garg; Hardeep Singh Malhotra; Rakesh Kumar Gupta; Rajesh Verma; Praveen Kumar Sharma
Journal:  Neuroradiol J       Date:  2015-12-11

3.  Neurocysticercosis: unraveling the nature of the single cysticercal granuloma.

Authors:  H H García; A E Gonzalez; S Rodriguez; V C W Tsang; E J Pretell; I Gonzales; R H Gilman
Journal:  Neurology       Date:  2010-08-17       Impact factor: 9.910

Review 4.  Neurocysticercosis in sub-Saharan Africa: a review of prevalence, clinical characteristics, diagnosis, and management.

Authors:  Andrea Sylvia Winkler
Journal:  Pathog Glob Health       Date:  2012-09       Impact factor: 2.894

5.  Frequency and Determinant Factors for Calcification in Neurocysticercosis.

Authors:  Javier A Bustos; Gianfranco Arroyo; Robert H Gilman; Percy Soto-Becerra; Isidro Gonzales; Herbert Saavedra; E Javier Pretell; Theodore E Nash; Seth E O'Neal; Oscar H Del Brutto; Armando E Gonzalez; Hector H Garcia
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 20.999

Review 6.  Managing neurocysticercosis: challenges and solutions.

Authors:  Yannick Fogoum Fogang; Abdoul Aziz Savadogo; Massaman Camara; Dènahin Hinnoutondji Toffa; Anna Basse; Adjaratou Djeynabou Sow; Mouhamadou Mansour Ndiaye
Journal:  Int J Gen Med       Date:  2015-10-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.